Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 107Unknown 64Terminated 10Active not recruiting 10Recruiting 5Withdrawn 3Suspended 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 19Biopsy 13Magnetic Resonance Spectroscopy 11Cyclophosphamide 4X-Rays 3Vincristine 3Nivolumab 3Doxorubicin 3venetoclax 2trastuzumab deruxtecan 2decitabine and cedazuridine drug combination 2Taxes 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Prednisone 2Ipilimumab 2Cetuximab 2CTLA-4 Antigen 2Azacitidine 2Actinium 2(225)Ac-DOTA-c(RGDyK) 2sargramostim 1relatlimab 1prednylidene 1olaparib 1neratinib 1mirdametinib 1ipatasertib 1iadademstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × NIH × Fluorouracil × Clear all
NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Suspended
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡